General Information of This Metabolic Reaction (MR) (ID: MR013612)
Formula Reactant NITD609 Metabolite M37 Product NITD609 Metabolite M14,M24,M32
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013610 NITD609 NITD609 Metabolite M37 Unclear NITD609 [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013611 NITD609 Metabolite M37 NITD609 Metabolite M18 Unclear NITD609 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013619 NITD609 Metabolite M40 NITD609 Metabolite M14,M24,M32 Unclear NITD609 [1]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013616 NITD609 Metabolite M14,M24,M32 NITD609 Metabolite M21.8,M23.5A Unclear NITD609 [1]
References
1 KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.